Inflammation and arterial function

Artery Research

Volumn 1, Issue 1, 2007, Pages 32-38

  Aznaouridis, Konstantinos A ^a   Stefanadis, Christodoulos I ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Arterial stiffness; Endothelial function; Inflammation; Wave reflection

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTERY; ARTERY DISEASE; ARTERY STIFFNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DRUG MECHANISM; ERECTILE DYSFUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

EID: 34250692514     PISSN: 18729312     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.artres.2007.03.005     Document Type: Article

References (55)

1. Vlachopoulos C., Aznaouridis K., and Stefanadis C. Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece. Heart 92 (2006) 1544-1550
2. Brunner H., Cockcroft J.R., Deanfield J., Donald A., Ferrannini E., Halcox J., et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the European society of hypertension. J Hypertens 23 (2005) 233-246
3. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
4. London G.M., Blacher J., Pannier B., Guerin A.P., Marchais S.J., and Safar M.E. Arterial wave reflections and survival in end-stage renal failure. Hypertension 38 (2001) 434-438
5. Williams B., Lacy P.S., Thom S.M., Cruickshank K., Stanton A., Collier D., et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113 (2006) 1213-1225
6. McEniery C.M., Yasmin, Hall I.R., Qasem A., Wilkinson I.B., Cockcroft J.R., and on behalf of the ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity. The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 46 (2005) 1753-1760
7. Wojciechowska W., Staessen J.A., Nawrot T., Cwynar M., Seidlerova J., Stolarz K., et al. Reference values in white Europeans for the arterial pulse wave recorded by means of the SphygmoCor device. Hypertens Res 29 (2006) 475-483
8. Hansson G.K. Inflammation, Atherosclerosis, and Coronary Artery Disease. N Engl J Med 352 (2005) 1685-1695
9. Wakabayashi I., and Masuda H. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta 365 (2006) 230-235
10. Diamant M., Lamb H.J., van de Ree M.A., Endert E.L., Groeneveld Y., Bots M.L., et al. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab 90 (2005) 1495-1501
11. Ferreira I., Henry R.M., Twisk J.W., van Mechelen W., Kemper H.C., and Stehouwer C.D. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness. The Amsterdam growth and health longitudinal study. Arch Intern Med 165 (2005) 875-882
12. Pirro M., Schillaci G., Savarese G., Gemelli F., Mannarino M.R., Siepi D., et al. Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia. Eur J Clin Invest 34 (2004) 335-341
13. Pietri P., Vyssoulis G., Vlachopoulos C., Zervoudaki A., Gialernios T., Aznaouridis K., et al. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens 24 (2006) 2231-2238
14. Mahmud A., and Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 46 (2005) 1118-1122
15. Kampus P., Muda P., Kals J., Ristimae T., Fischer K., Teesalu R., et al. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol 112 (2006) 46-51
16. Mahmud A., and Feely J. Adiponectin and arterial stiffness. Am J Hypertens 18 (2005) 1543-1548
17. Vlachopoulos C., Aznaouridis K., Vyssoulis G., Zervoudaki A., Pietri P., Kyvelou S.M., et al. Large-artery stiffening is associated with increased fibrinogen level in hypertensive patients. World Congress of Cardiology (2006) [abstract]
18. Vlachopoulos C., Aznaouridis K., Ioakeimidis N., Rokkas K., Vasiliadou C., Alexopoulos N., et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 22 (2006) 2640-2648
19. Vlachopoulos C., Ioakeimidis N., Tsekoura D., Aznaouridis K., Rokkas K., Alexopoulos N., et al. Aortic stiffness and carotid intima media thickness are associated with penile doppler findings in patients with vasculogenic erectile dysfunction. AHA Scientific Sessions (2006) [abstract]
20. Kullo I.J., Seward J.B., Bailey K.R., Bielak L.F., Grossardt B.R., Sheedy II P.F., et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 18 (2005) 1123-1129
21. Yasmin, McEniery C.M., Wallace S., Mackenzie I.S., Cockcroft J.R., and Wilkinson I.B. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 24 (2004) 969-974
22. Vlachopoulos C., Aznaouridis K., Dima I., Ioakeimidis N., Vasiliadou C., Zervoudaki A., et al. Negative association between serum levels of matrix metalloproteinases-2 and -9 and aortic stiffness in healthy adults. Int J Cardiol (2007 Feb 6) [Epub ahead of print]
23. Yasmin, Wallace S., McEniery C.M., Dakham Z., Pusalkar P., Maki-Petaja K., et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 25 (2005) 372-378
24. Tronc F., Mallat Z., Lehoux S., Wassef M., Esposito B., and Tedgui A. Role of matrix metalloproteinases in blood flow-induced arterial enlargement. Interaction with NO. Arterioscler Thromb Vasc Biol 20 (2000) e120-e126
25. Vlachopoulos C., Aznaouridis K., Pietri P., Ioakeimidis N., and Stefanadis C. White blood cell count is a marker of wave reflections and arterial stiffness in healthy individuals. Atherosclerosis 187 (2006) 218-219
26. Volanen I., Jarvisalo M.J., Vainionpaa R., Arffman M., Kallio K., Angle S., et al. Increased aortic intima-media thickness in 11-year-old healthy children with persistent Chlamydia pneumoniae seropositivity. Arterioscler Thromb Vasc Biol 26 (2006) 649-655
27. Roman M.J., Devereux R.B., Schwartz J.E., Lockshin M.D., Paget S.A., Davis A., et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 46 (2005) 194-199
28. Klocke R., Cockcroft J.R., Taylor G.J., Hall I.R., and Blake D.R. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 62 (2003) 414-418
29. Datta D., Ferrell W.R., Sturrock R.D., Jadhav S.T., and Sattar N. Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis. Atherosclerosis (2006 Jun 22) [Epub ahead of print]
30. Booth A.D., Wallace S., McEniery C.M., Yasmin, Brown J., Jayne D.R., et al. Inflammation and arterial stiffness in systemic vasculitis. A model of vascular inflammation. Arthr Rheum 50 (2004) 581-588
31. Senzaki H., Chen C.-H., Ishido H., Masutani S., Matsunaga T., Taketazu M., et al. Arterial hemodynamics in patients after Kawasaki disease. Circulation 111 (2005) 2119-2125
32. Charakida M., Donald A.E., Green H., Clare Storry, Margaret Clapson, Caslake M., et al. Early structural and functional changes of the vasculature in HIV-infected children. Impact of disease and antiretroviral therapy. Circulation 112 (2005) 103-109
33. Protogerou A., Lekakis J., Stamatelopoulos K., Aznaouridis K., Karatzis E., Ikonomidis I., et al. Arterial wall characteristics in patients with Adamantiades-Behcet's disease. Adv Exp Med Biol 528 (2003) 399-404
34. Protogerou A.D., Lekakis J., Ikonomidis I., Stamatelopoulos K., Aznaouridis K., KaratziS E.N., et al. Pressure wave reflections, central blood pressure, and aortic stiffness in patients with Adamantiades-Behcet's disease. A cross-sectional case-control study underlining the role of chronic corticosteroid treatment. Am J Hypertens 19 (2006) 660-666
35. Ikonomidis I., Aznaouridis K., Protogerou A., Stamatelopoulos K., Markomihelakis N., Papamichael C., et al. Arterial wave reflections are associated with left ventricular diastolic dysfunction in Adamantiades-Behcet's disease. J Card Fail 12 (2006) 458-463
36. Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., and Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351 (2004) 2611-2618
37. Charakida M., Donald A.E., Terese M., Leary S., Halcox J.P., Ness A., et al. for the ALSPAC (Avon Longitudinal Study of Parents and Children) Study Team. Endothelial dysfunction in childhood infection. Circulation 111 (2005) 1660-1665
38. Hingorani A.D., Cross J., Kharbanda R.K., Mullen M., Bhagat K., Taylor M., et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 102 (2000) 994-999
39. Kharbanda R.K., Walton B., Allen M., Klein N., Hingorani A.D., MacAllister R.J., et al. Prevention of inflammation-induced endothelial dysfunction. A novel vasculo-protective action of aspirin. Circulation 105 (2002) 2600-2604
40. Clapp B.R., Hirschfield G.M., Storry C., Gallimore J.R., Stidwill R.P., Singer M., et al. Inflammation and endothelial function. Direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 111 (2005) 1530-1536
41. Vlachopoulos C., Dima I., Aznaouridis K., Vasiliadou C., Ioakeimidis N., Aggeli C., et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 112 (2005) 2193-2200
42. Wilkinson I.B., Franklin S.S., and Cockcroft J.R. Nitric oxide and the regulation of large artery stiffness. From physiology to pharmacology. Hypertension 44 (2004) 112-116
43. McNulty M., Mahmud A., Spiers P., and Feely J. Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects. J Hum Hypertens 20 (2006) 867-873
44. Verma S., Wang C.H., Li S.H., Dumont A.S., Fedak P.W., Badiwala M.V., et al. A self-fulfilling prophecy. C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106 (2002) 913-919
45. Taylor K.E., Giddings J.C., and van den Berg C.W. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol 25 (2005) 1225-1230
46. Pepys M.B., Hirschfield G.M., Tennent G.A., Gallimore J.R., Kahan M.C., Bellotti V., et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440 (2006) 1217-1221
47. Chenevard R., Hürlimann D., Béchir M., Enseleit F., Spieker L., Hermann M., et al. Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation 107 (2003) 405-409
48. Vlachopoulos C., Bratsas A., Aznaouridis K., Ioakeimidis N., Vasiliadou C., Tousoulis D., et al. Celecoxib, a selective cyclooxygenase-2 inhibitor prevents the inflammatory activation acutely induced by smoking. World Congress of Cardiology (2006) [abstract]
49. Vlachopoulos C., Bratsas A., Aznaouridis K., Ioakeimidis N., Xaplanteris P., Alexopoulos N., et al. Selective cyclooxygenase-2 inhibition by celecoxib abrogates the acute smoking-induced vascular dysfunction. J Am Coll Cardiol 47 Suppl. 1 (2006) 356A [abstract]
50. Van Doornum S., McColl G., and Wicks I.P. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford) 44 (2005) 1428-1432
51. Maki-Petaja K.M., Hall F.C., Booth A.D., Wallace S.M., Yasmin, Bearcroft P.W., et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-α therapy. Circulation 114 (2006) 1185-1192
52. Booth A.D., Jayne D.R.Q., Kharbanda R.K., McEniery C.M., Mackenzie I.S., Brown J., et al. Infliximab improves endothelial dysfunction in systemic vasculitis. A model of vascular inflammation. Circulation 109 (2004) 1718-1723
53. Van Doornum S., McColl G., and Wicks I.P. Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis 63 (2004) 1571-1575
54. Tousoulis D., Antoniades C., Bosinakou E., Kotsopoulou M., Pitsavos C., Vlachopoulos C., et al. Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure. Atherosclerosis 178 (2005) 359-363
55. Aznaouridis K., Vlachopoulos C., Dagre A., Masoura C., Vasiliadou C., Dima I., et al. Atorvastatin abrogates the deterioration of endothelial function induced by acute inflammation in dyslipidemic patients. J Am Coll Cardiol 49 Suppl. 1 (2007) 381A [abstract]